Treatment of B-cell acute lymphoblastic leukemia has improved thanks to CAR T therapies, but relapse is still very common. An ...
Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.
Some stay in the marrow and develop into B lymphocytes (B cells); others travel to the thymus and become T lymphocytes (T cells). These two cell types have different roles. B lymphocytes produce ...
News Medical on MSN1d
Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumorsB-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...
Ten years of substantial work by Université de Montréal immunologist Nathalie Labrecque's team at the Montreal Clinical ...
Figure 1: SLC, ELC and BCA-1 cooperate in the recruitment and localization of T and B cells within secondary lymphoid organs. The complex migratory pathways of lymphocytes are tightly regulated by ...
The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...
B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback